Characterization of the stimulatory effect of medroxyprogesterone acetate and chlormadinone acetate on growth factor treated normal human breast epithelial cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 98, Issue 2-3, 2006, Pages 174-178

  Krämer, Elizabeth A ^a   Seeger, Harald ^a   Krämer, Bernhard ^a   Wallwiener, Diethelm ^a   Mueck, Alfred O ^a  

^a University Womens' Hospital Tuebingen   (Germany)

Author keywords

Breast epithelial cells; Chlormadinone acetate; Growth factors; Medroxyprogesterone acetate; Proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CHLORMADINONE ACETATE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN;

ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN CELL;

BREAST; CELL PROLIFERATION; CELLS, CULTURED; CHLORMADINONE ACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FEMALE; GROWTH SUBSTANCES; HORMONE REPLACEMENT THERAPY; HUMANS; MEDROXYPROGESTERONE 17-ACETATE;

EID: 31444453284     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.11.002     Document Type: Article

References (13)

1. M. Clemons, and P. Goss Estrogen and the risk of breast cancer New. Engl. J. Med. 344 2001 276 285
2. Writing Group for the Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, JAMA 288 (2002) 321-333.
3. Million Women Study Collaborators, Breast Cancer and hormone replacement therapy in the Million Women Study, Lancet, 362 (2003) 419-427.
4. The Women's Health Initiative Steering Committee, Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy, JAMA 291 (2004) 1701-1712.
5. K.M.W. Rahmean, and F.H. Sarkar Steroid hormone mimics: molecular mechanisms of cell growth and apoptosis in normal and malignant mammary epithelial cells J. Steroid Biochem. Mol. Biol. 80 2002 191 201
6. P.E. Andreotti, J.T. Thornthwaite, and I.S. Morse ATP tumor chemosensitivity assay P.E. Stanley L.J. Kricka Bioluminescence and Chemoluminescence: Current Status 1991 John Wiley & Sons Chichester 417 420
7. A.V. Makarevich, A.V. Sirotkin, P. Chrenek, and J. Bulla Effect of epidermal growth factor (EGF) on steroid and cyclic nucleotide secretion, proliferation and ERK-related MAP-kinase in cultured rabbit granulosa cells Exp. Clin. Endocrinol. Diabetes 110 2002 124 129
8. L.J. Hosfeth, A.M. Raafat, J.R. Osuch, D.R. Pathak, C.A. Slomski, and S.Z. Haslam Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast J. Clin. Endocrinol. Metab. 84 1999 4559 4565
9. J.M. Cline, G.S. Soderqvist, E. von Schoultz, L. Skoog, and B. von Schoulz Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques Am. J. Obstet. Gynecol. 174 1996 93 100
10. K. Ebeling, R. Ray, P. Nischan, D.B. Thomas, D. Kunde, and H. Stalsberg Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study Br. J. Cancer 63 1991 804 808
11. P. Nischan, and K. Ebeling Oral contraceptives containing chlormadinone acetate and cancer incidence at selected sites in the German Democratic Republic - a correlation analysis Int. J. Cancer 34 1984 671 674
12. C.A. Lange, J.K. Richer, T. Shen, and K.B. Horwitz Convergence of progesterone and epidermal growth factor signaling in breast cancer J. Biol. Chem. 273 1998 31308 31316
13. ®. A randomised, single-blind, triple cross-over bioavailability study in menopausal women Maturitas 18 1994 229 238